AtaiBeckley (ATAI) Other Non Operating Income (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Other Non Operating Income of $87000.0 for Q1 2026, down 80.92% year-over-year from $456000.0 in Q1 2025, and down 80.92% quarter-over-quarter from $456000.0 in Q1 2025.
Powered by 
Analysis
AtaiBeckley (ATAI) Other Non Operating Income (2020 - 2026) Analysis & Trends
AtaiBeckley has reported Other Non Operating Income for 6 years, with the latest figure at -$650000.0 in Q3 2025.
- Quarterly Other Non Operating Income changed N/A year-over-year to -$650000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$3.4 million (down 1027.45% YoY) and the FY2024 annual result came in at -$1.3 million, down 41.28% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $87000.0, down from $456000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $456000.0 in Q1 2025, with the low at $87000.0 in Q1 2026.
- A 5-year average of -$53428.6 and a median of -$209000.0 in 2021 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income slumped 544.19% in 2024, then jumped 9220.0% in 2025.
- Over 5 years, Other Non Operating Income stood at $174000.0 in 2021, then plunged by 316.67% to -$377000.0 in 2022, then increased by 20.16% to -$301000.0 in 2023, then plunged by 544.19% to -$1.9 million in 2024, then soared by 66.48% to -$650000.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$650000.0, -$1.3 million, and $456000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | AtaiBeckley | 1.60 Bn | 1.60 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 76,000.00 |
| Mar 31, 2026 | -409,000.00 |
| Sep 30, 2025 | -650,000.00 |
| Jun 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 456,000.00 |
| Mar 31, 2025 | 456,000.00 |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | -2.08 Mn |
| Jun 30, 2024 | -667,000.00 |
| Mar 31, 2024 | -216,000.00 |
| Dec 31, 2023 | -301,000.00 |
| Sep 30, 2023 | -308,000.00 |
| Jun 30, 2023 | -34,000.00 |
| Mar 31, 2023 | -837,000.00 |
| Dec 31, 2022 | -4.61 Mn |
| Sep 30, 2022 | 4.47 Mn |
| Jun 30, 2022 | 4.88 Mn |
| Mar 31, 2022 | 2.16 Mn |
| Dec 31, 2021 | 3.04 Mn |